Journal
JOURNAL OF IMMUNOLOGY
Volume 180, Issue 4, Pages 2099-2106Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.180.4.2099
Keywords
-
Categories
Funding
- Intramural NIH HHS Funding Source: Medline
Ask authors/readers for more resources
In the induction of an immune response, IL-1511 alpha on APCs transpresents IL-15 to NK and CD8(+)/CD44(high) T cells that express the IL-2/15R beta and gamma c subunits only. In this study, we show data mimicking this transpresentation by using IL-15 preassociated with a chimeric protein that is comprised of the extracellular domain of murine IL-1511a and the Fe portion of human IgG1. When tested in vitro, IL-15R alpha-IgG1-Fc strongly increased the IL-15-mediated proliferation of murine NK and CD8(+)/CD44(high) T cells. The effect of IL-15R alpha-IgG1-Fc was dependent on the presence of both IgG1-Fc and IL-15R alpha. When injected into mice, IL-15R alpha-IgG1-Fc enhanced the capacity of IL-15 to expand the number of NK and CD8(+)/CD44(high) T cells. The effect on cell numbers in vivo also depended on Fe receptor binding because reduced expansion was observed in FcR gamma(-/-) mice. NK cells cultured in IL-15/IL-15R alpha-IgG1-Fc complex gained cytotoxic activity toward a number of NK-sensitive targets. When mice bearing the NK-sensitive syngeneic tumor B16 were treated, the presence of IL-15R alpha-IgG1-Fc increased the antitumor activity of IL-15. Thus, a preassociation with IL-15R alpha-IgG1-Fc enhances the activities of IL-15 in vivo and in vitro that may be useful in the treatment of tumors.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available